Literature DB >> 8537553

Recurrent dermatofibrosarcoma protuberans with myxoid and fibrosarcomatous changes paralleled by loss of CD34 expression.

N Sato1, K Kimura, Y Tomita.   

Abstract

A 38-year-old woman complained of recurrent nodules on her anterior chest wall. She noticed the first nodule at the age of 12 and has since undergone surgical removal a total of 31 times. Finally, wide resection of parts of the rib cartilage and sternum and chest wall reconstruction were required. Histopathological examination of a series of surgical specimens were reevaluated. Immunohistochemical staining of the tumors by anti-CD34 antibody provided a definite diagnosis of dermatofibrosarcoma protuberans (DFSP). A noteworthy result was that her DFSP did not always express CD34; the recurrent tumors with myxoid and fibrosarcomatous changes lost their CD34 expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8537553     DOI: 10.1111/j.1346-8138.1995.tb03895.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  3 in total

1.  Clinicopathological features of dermatofibrosarcoma protuberans.

Authors:  Noppadol Larbcharoensub; Jitchai Kayankarnnavee; Suda Sanpaphant; Kidakorn Kiranantawat; Chewarat Wirojtananugoon; Vorachai Sirikulchayanonta
Journal:  Oncol Lett       Date:  2015-11-24       Impact factor: 2.967

Review 2.  Current Update on the Molecular Biology of Cutaneous Sarcoma: Dermatofibrosarcoma Protuberans.

Authors:  Takeshi Iwasaki; Hidetaka Yamamoto; Yoshinao Oda
Journal:  Curr Treat Options Oncol       Date:  2019-03-14

3.  Immunohistochemical analysis of CXCR4 expression in fibrohistiocytic tumors.

Authors:  Seiko Toyozawa; Yuki Yamamoto; Yuko Ishida; Toshikazu Kondo; Yasushi Nakamura; Fukumi Furukawa
Journal:  Acta Histochem Cytochem       Date:  2010-04-07       Impact factor: 1.938

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.